CAPN1
Calpain-1 catalytic subunit
Also known as: CAN1_HUMAN, CANP, CANPL1, muCANP, muCL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07384
- Gene
- CAPN1
- Ensembl
- ENSG00000014216
- Chromosome
- 11
- Canonical length
- 714 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes the large subunit of the ubiquitous enzyme, calpain 1. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
714 residues, UniProt reviewed canonical sequence.
>P07384|CAPN1
1 MSEEIITPVY CTGVSAQVQK QRARELGLGR HENAIKYLGQ DYEQLRVRCL QSGTLFRDEA
61 FPPVPQSLGY KDLGPNSSKT YGIKWKRPTE LLSNPQFIVD GATRTDICQG ALGDCWLLAA
121 IASLTLNDTL LHRVVPHGQS FQNGYAGIFH FQLWQFGEWV DVVVDDLLPI KDGKLVFVHS
181 AEGNEFWSAL LEKAYAKVNG SYEALSGGST SEGFEDFTGG VTEWYELRKA PSDLYQIILK
241 ALERGSLLGC SIDISSVLDM EAITFKKLVK GHAYSVTGAK QVNYRGQVVS LIRMRNPWGE
301 VEWTGAWSDS SSEWNNVDPY ERDQLRVKME DGEFWMSFRD FMREFTRLEI CNLTPDALKS
361 RTIRKWNTTL YEGTWRRGST AGGCRNYPAT FWVNPQFKIR LDETDDPDDY GDRESGCSFV
421 LALMQKHRRR ERRFGRDMET IGFAVYEVPP ELVGQPAVHL KRDFFLANAS RARSEQFINL
481 REVSTRFRLP PGEYVVVPST FEPNKEGDFV LRFFSEKSAG TVELDDQIQA NLPDEQVLSE
541 EEIDENFKAL FRQLAGEDME ISVKELRTIL NRIISKHKDL RTKGFSLESC RSMVNLMDRD
601 GNGKLGLVEF NILWNRIRNY LSIFRKFDLD KSGSMSAYEM RMAIESAGFK LNKKLYELII
661 TRYSEPDLAV DFDNFVCCLV RLETMFRFFK TLDTDLDGVV TFDLFKWLQL TMFALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAPN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 267 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 267 nTPM
- skin: 118 nTPM
- salivary gland: 114 nTPM
- vagina: 113 nTPM
- cervix: 98 nTPM
- fallopian tube: 87 nTPM
Single-cell type
- esophageal apical cells: 893 nCPM
- platelets: 663 nCPM
- esophageal suprabasal cells: 471 nCPM
- cytotrophoblasts: 293 nCPM
- esophageal basal cells: 281 nCPM
- megakaryocytes: 266 nCPM
Immune cell
- basophil: 88 nTPM
- eosinophil: 78 nTPM
- total PBMC: 75 nTPM
- classical monocyte: 58 nTPM
- intermediate monocyte: 51 nTPM
- myeloid DC: 49 nTPM
Brain region
- pons: 93 nTPM
- thalamus: 85 nTPM
- medulla oblongata: 84 nTPM
- spinal cord: 76 nTPM
- hypothalamus: 73 nTPM
- midbrain: 71 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CAPN1.
Disease | AllUniProt
Conditions CAPN1 is implicated in, by any mechanism.
- Spastic paraplegia 76, autosomal recessive (SPG76) MIM:616907
Disease | GeneticClinVar
50 pathogenic / likely-pathogenic of 393 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive spastic paraplegia type 76
- CAPN1-related disorder
- Hereditary spastic paraplegia 11
- Gastric cancer
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.68
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mammary gland involution
- NMDA selective glutamate receptor signaling pathway
- positive regulation of cell population proliferation
- proteolysis
- receptor catabolic process
- regulation of catalytic activity
- regulation of macroautophagy
- self proteolysis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine peptidase, cysteine active site
- Peptidase C2, calpain, catalytic domain
- EF-hand domain
- EF-hand domain pair
- EF-Hand 1, calcium-binding site
- Peptidase C2, calpain, large subunit, domain III
- Peptidase C2, calpain, domain III
- Peptidase C2, calpain family
- Calpain subdomain III
- Calpain large subunit, domain III superfamily
- Papain-like cysteine peptidase superfamily
- Calpain family cysteine protease
- Calpain large subunit, domain III
- EF-hand domain pair
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CAPN1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAPN1 as an antibody target. Whether an autoantibody or antibody against CAPN1 could matter depends on whether native CAPN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAPN1 is annotated at the cell surface, where native CAPN1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CAPN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...